类器官构建与应用专题 |
|
|
|
|
肺类器官模型在感染性肺系病研究中的应用及展望* |
石瑾1,刘柯2,丁军颖2,**() |
1 首都医科大学附属北京中医医院 北京 100010 2 首都医科大学附属北京中医医院 北京市中医药研究所 中医感染性疾病基础研究北京市重点实验室 北京 100010 |
|
Application and Prospects of Lung Organoid Models in the Study of Infectious Lung Diseases |
SHI Jin1,LIU Ke2,DING Jun-ying2,**() |
1 Department of Clinical Laboratory, Beijing Hospital of Traditional Chinese Medicine (TCM), Capital Medical University, Beijing 100010, China 2 Beijing Key Laboratory of Basic Research with TCM on Infectious Diseases, Beijing Institute of Chinese Medicine, Beijing Hospital of TCM, Capital Medical University, Beijing 100010, China |
[1] |
Gruzieva O, Jeong A, He S Z, et al. Air pollution, metabolites and respiratory health across the life-course. European Respiratory Review: an Official Journal of the European Respiratory Society, 2022, 31(165): 220038.
doi: 10.1183/16000617.0038-2022
|
[2] |
Corrò C, Novellasdemunt L, Li V S W. A brief history of organoids. American Journal of Physiology Cell Physiology, 2020, 319(1): C151-C165.
doi: 10.1152/ajpcell.00120.2020
|
[3] |
Calvert B A, Ryan Firth A L. Application of iPSC to modelling of respiratory diseases. Advances in Experimental Medicine and Biology, 2020, 1237: 1-16.
doi: 10.1007/5584_2019_430
pmid: 31468358
|
[4] |
Chen J Y, Na F F. Organoid technology and applications in lung diseases: models, mechanism research and therapy opportunities. Frontiers in Bioengineering and Biotechnology, 2022, 10: 1066869.
doi: 10.3389/fbioe.2022.1066869
|
[5] |
Shannon J M, Mason R J, Jennings S D. Functional differentiation of alveolar type II epithelial cells in vitro: effects of cell shape, cell-matrix interactions and cell-cell interactions. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1987, 931(2): 143-156.
doi: 10.1016/0167-4889(87)90200-X
|
[6] |
Köpf-Maier P, Zimmermann B. Organoid reorganization of human tumors under in vitro conditions. Cell and Tissue Research, 1991, 264(3): 563-576.
pmid: 1868523
|
[7] |
Rock J R, Onaitis M W, Rawlins E L, et al. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(31): 12771-12775.
|
[8] |
Barkauskas C E, Cronce M J, Rackley C R, et al. Type 2 alveolar cells are stem cells in adult lung. The Journal of Clinical Investigation, 2013, 123(7): 3025-3036.
doi: 10.1172/JCI68782
|
[9] |
Wong A P, Bear C E, Chin S, et al. Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein. Nature Biotechnology, 2012, 30(9): 876-882.
pmid: 22922672
|
[10] |
Dye B R, Hill D R, Ferguson M A H, et al. In vitro generation of human pluripotent stem cell derived lung organoids. eLife, 2015, 4: e05098.
doi: 10.7554/eLife.05098
|
[11] |
Tan Q, Choi K M, Sicard D, et al. Human airway organoid engineering as a step toward lung regeneration and disease modeling. Biomaterials, 2017, 113: 118-132.
doi: S0142-9612(16)30596-8
pmid: 27815996
|
[12] |
李晓娜, 齐先梅, 张田甜, 等. 类器官培养技术在呼吸系统疾病中的应用. 中国病理生理杂志, 2023, 39(2):366-372.
|
|
Li X N, Qi X M, Zhang T T, et al. Application of organoid culture technology in respiratory diseases. Chinese Journal of Pathophysiology, 2023, 39(2):366-372.
|
[13] |
Hild M, Jaffe A B. Production of 3-D airway organoids from primary human airway basal cells and their use in high-throughput screening. Current Protocols in Stem Cell Biology, 2016, 37(1): IE.9.1-IE.9.15.
|
[14] |
杨换连, 邱飞, 王国权, 等. 肿瘤类器官在药物筛选和个性化用药中的研究进展. 中国生物工程杂志, 2022, 42(6): 47-53.
|
|
Yang H L, Qiu F, Wang G Q, et al. Progress in the research and application of tumor organoids in drug screening and personalized drug treatment. China Biotechnology, 2022, 42(6): 47-53.
|
[15] |
Sachs N, Papaspyropoulos A, Zomer-van Ommen D D, et al. Long-term expanding human airway organoids for disease modeling. The EMBO Journal, 2019, 38(4): e100300.
doi: 10.15252/embj.2018100300
|
[16] |
Miller A J, Dye B R, Ferrer-Torres D, et al. Generation of lung organoids from human pluripotent stem cells in vitro. Nature Protocols, 2019, 14(2): 518-540.
doi: 10.1038/s41596-018-0104-8
|
[17] |
Han Y L, Duan X H, Yang L L, et al. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature, 2021, 589(7841): 270-275.
doi: 10.1038/s41586-020-2901-9
|
[18] |
González Aparicio L J, López C B, Felt S A. A virus is a community: diversity within negative-sense RNA virus populations. Microbiology and Molecular Biology Reviews: MMBR, 2022, 86(3): e0008621.
|
[19] |
Han Y L, Yang L L, Lacko L A, et al. Human organoid models to study SARS-CoV-2 infection. Nature Methods, 2022, 19(4): 418-428.
doi: 10.1038/s41592-022-01453-y
pmid: 35396481
|
[20] |
Salahudeen A A, Choi S S, Rustagi A, et al. Progenitor identification and SARS-CoV-2 infection in human distal lung organoids. Nature, 2020, 588(7839): 670-675.
doi: 10.1038/s41586-020-3014-1
|
[21] |
Mannar D, Saville J W, Zhu X, et al. SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex. Science, 2022, 375(6582): 760-764.
doi: 10.1126/science.abn7760
pmid: 35050643
|
[22] |
Huang J, Hume A J, Abo K M, et al. SARS-CoV-2 infection of pluripotent stem cell-derived human lung alveolar type 2 cells elicits a rapid epithelial-intrinsic inflammatory response. Cell Stem Cell, 2020, 27(6): 962-973.e7.
doi: 10.1016/j.stem.2020.09.013
pmid: 32979316
|
[23] |
Ampomah P B, Lim L H K. Influenza A virus-induced apoptosis and virus propagation. Apoptosis, 2020, 25(1): 1-11.
doi: 10.1007/s10495-019-01575-3
|
[24] |
Hamilton B S, Whittaker G R. Cleavage activation of human-adapted influenza virus subtypes by kallikrein-related peptidases 5 and 12. Journal of Biological Chemistry, 2013, 288(24): 17399-17407.
doi: 10.1074/jbc.M112.440362
pmid: 23612974
|
[25] |
Wang D, Li C, Chiu M C, et al. SPINK 6 inhibits human airway serine proteases and restricts influenza virus activation. EMBO Molecular Medicine, 2022, 14(1): e14485.
doi: 10.15252/emmm.202114485
|
[26] |
Salgueiro L, Kummer S, Sonntag-Buck V, et al. Generation of human lung organoid cultures from healthy and tumor tissue to study infectious diseases. Journal of Virology, 2022, 96(7): e0009822.
|
[27] |
Zhao L, Yan Y Z, Dai Q S, et al. Development of novel anti-influenza thiazolides with relatively broad-spectrum antiviral potentials. Antimicrobial Agents and Chemotherapy, 2020, 64(7): e00222-20.
|
[28] |
田树凤, 邓继岿. 儿童副流感病毒感染的临床诊治进展. 中国实用儿科杂志, 2020, 35(11): 905-908.
|
|
Tian S F, Deng J K. Progress in clinical diagnosis and treatment of parainfluenza virus infection in children. Chinese Journal of Practical Pediatrics, 2020, 35(11): 905-908.
|
[29] |
Iketani S, Shean R C, Ferren M, et al. Viral entry properties required for fitness in humans are lost through rapid genomic change during viral isolation. mBio, 2018, 9(4): e00898-18.
|
[30] |
Porotto M, Ferren M, Chen Y W, et al. Authentic modeling of human respiratory virus infection in human pluripotent stem cell-derived lung organoids. mBio, 2019, 10(3): e00723-19.
|
[31] |
Collins P L, Fearns R, Graham B S. Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. Current Topics in Microbiology and Immunology, 2013, 372: 3-38.
doi: 10.1007/978-3-642-38919-1_1
pmid: 24362682
|
[32] |
Chen Y W, Huang S X, de Carvalho A L R T, et al. A three-dimensional model of human lung development and disease from pluripotent stem cells. Nature Cell Biology, 2017, 19(5): 542-549.
doi: 10.1038/ncb3510
|
[33] |
Gellatly S L, Hancock R E W. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathogens and Disease, 2013, 67(3): 159-173.
doi: 10.1111/2049-632X.12033
pmid: 23620179
|
[34] |
杨晓庆, 孙平, 薛寒, 等. 铜绿假单胞菌Ⅲ型分泌系统分泌蛋白ExoU与耐药性的关系研究. 中国临床药理学杂志, 2022, 38(19): 2324-2328.
|
|
Yang X Q, Sun P, Xue H, et al. Investigation of the relationship between secretry protein ExoU of Pseudomonas aeruginosa type 3 secretion system and drug resistance. The Chinese Journal of Clinical Pharmacology, 2022, 38(19): 2324-2328.
|
[35] |
Bagayoko S, Leon-Icaza S A, Pinilla M, et al. Host phospholipid peroxidation fuels ExoU-dependent cell necrosis and supports Pseudomonas aeruginosa-driven pathology. PLoS Pathogens, 2021, 17(9): e1009927.
|
[36] |
Tang M X, Liao S M, Qu J, et al. Evaluating bacterial pathogenesis using a model of human airway organoids infected with Pseudomonas aeruginosa biofilms. Microbiology Spectrum, 2022, 10(6): e0240822.
|
[37] |
Ali M, LaCanna R, Lian Z R, et al. Transcriptional responses to injury of regenerative lung alveolar epithelium. iScience, 2022, 25(8): 104843.
doi: 10.1016/j.isci.2022.104843
|
[38] |
Sempere J, Rossi S A, Chamorro-Herrero I, et al. Minilungs from human embryonic stem cells to study the interaction of Streptococcus pneumoniae with the respiratory tract. Microbiology Spectrum, 2022, 10(3): e45322.
|
[39] |
Domínguez J, Boeree M J, Cambau E, et al. Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement. The Lancet Infectious Diseases, 2023, 23(4): e122-e137.
doi: 10.1016/S1473-3099(22)00875-1
|
[40] |
杨天立, 王向东, 白楠, 等. 肺类器官:研究人类肺部发育和疾病的新途径. 解放军医学院学报, 2021, 42(6):658-664.
|
|
Yang T L, Wang X D, Bai N, et al. Lung organoids: a new way to study human lung development and diseases. Academic Journal of Chinese Pla Medical School, 2021, 42(6):658-664.
|
[41] |
Iakobachvili N, Leon-Icaza S A, Knoops K, et al. Mycobacteria-host interactions in human bronchiolar airway organoids. Molecular Microbiology, 2022, 117(3): 682-692.
doi: 10.1111/mmi.v117.3
|
[42] |
Pagán A J, Ramakrishnan L. The formation and function of granulomas. Annual Review of Immunology, 2018, 36: 639-665.
doi: 10.1146/annurev-immunol-032712-100022
pmid: 29400999
|
[43] |
Elkington P, Lerm M, Kapoor N, et al. In vitro granuloma models of tuberculosis: potential and challenges. The Journal of Infectious Diseases, 2019, 219(12): 1858-1866.
doi: 10.1093/infdis/jiz020
|
[44] |
Heo I, Dutta D, Schaefer D A, et al. Modelling Cryptosporidium infection in human small intestinal and lung organoids. Nature Microbiology, 2018, 3(7): 814-823.
doi: 10.1038/s41564-018-0177-8
|
[45] |
俞东红, 曹华, 王心睿. 类器官的研究进展及应用. 生物工程学报, 2021, 37(11): 3961-3974.
|
|
Yu D H, Cao H, Wang X R. Advances and applications of organoids: a review. Chinese Journal of Biotechnology, 2021, 37(11): 3961-3974.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|